Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

471 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immuno-PET Imaging of the Programmed Cell Death-1 Ligand (PD-L1) Using a Zirconium-89 Labeled Therapeutic Antibody, Avelumab.
Jagoda EM, Vasalatiy O, Basuli F, Opina ACL, Williams MR, Wong K, Lane KC, Adler S, Ton AT, Szajek LP, Xu B, Butcher D, Edmondson EF, Swenson RE, Greiner J, Gulley J, Eary J, Choyke PL. Jagoda EM, et al. Among authors: gulley j. Mol Imaging. 2019 Jan-Dec;18:1536012119829986. doi: 10.1177/1536012119829986. Mol Imaging. 2019. PMID: 31044647 Free PMC article.
Costimulatory molecules as adjuvants for immunotherapy.
Hodge JW, Greiner JW, Tsang KY, Sabzevari H, Kudo-Saito C, Grosenbach DW, Gulley JL, Arlen PM, Marshall JL, Panicali D, Schlom J. Hodge JW, et al. Among authors: gulley jl. Front Biosci. 2006 Jan 1;11:788-803. doi: 10.2741/1837. Front Biosci. 2006. PMID: 16146771 Review.
TRICOM vector based cancer vaccines.
Garnett CT, Greiner JW, Tsang KY, Kudo-Saito C, Grosenbach DW, Chakraborty M, Gulley JL, Arlen PM, Schlom J, Hodge JW. Garnett CT, et al. Among authors: gulley jl. Curr Pharm Des. 2006;12(3):351-61. doi: 10.2174/138161206775201929. Curr Pharm Des. 2006. PMID: 16454749 Review.
Progress in prostate cancer imaging.
Gulley JL, Emberton M, Kurhanewicz J, Choyke P. Gulley JL, et al. Urol Oncol. 2012 Nov-Dec;30(6):938-9. doi: 10.1016/j.urolonc.2012.09.008. Urol Oncol. 2012. PMID: 23218070 Free PMC article. Review.
Phase II clinical trial of cediranib in patients with metastatic castration-resistant prostate cancer.
Dahut WL, Madan RA, Karakunnel JJ, Adelberg D, Gulley JL, Turkbey IB, Chau CH, Spencer SD, Mulquin M, Wright J, Parnes HL, Steinberg SM, Choyke PL, Figg WD. Dahut WL, et al. Among authors: gulley jl. BJU Int. 2013 Jun;111(8):1269-80. doi: 10.1111/j.1464-410X.2012.11667.x. Epub 2013 Feb 18. BJU Int. 2013. PMID: 23419134 Free PMC article. Clinical Trial.
Therapeutic cancer vaccines.
Schlom J, Hodge JW, Palena C, Tsang KY, Jochems C, Greiner JW, Farsaci B, Madan RA, Heery CR, Gulley JL. Schlom J, et al. Among authors: gulley jl. Adv Cancer Res. 2014;121:67-124. doi: 10.1016/B978-0-12-800249-0.00002-0. Adv Cancer Res. 2014. PMID: 24889529 Free PMC article. Review.
Prospective Study Evaluating Na18F PET/CT in Predicting Clinical Outcomes and Survival in Advanced Prostate Cancer.
Apolo AB, Lindenberg L, Shih JH, Mena E, Kim JW, Park JC, Alikhani A, McKinney YY, Weaver J, Turkbey B, Parnes HL, Wood LV, Madan RA, Gulley JL, Dahut WL, Kurdziel KA, Choyke PL. Apolo AB, et al. Among authors: gulley jl. J Nucl Med. 2016 Jun;57(6):886-92. doi: 10.2967/jnumed.115.166512. Epub 2016 Jan 21. J Nucl Med. 2016. PMID: 26795292 Free PMC article. Clinical Trial.
471 results